These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators. Liu ZD, Kayyali R, Hider RC, Porter JB, Theobald AE. J Med Chem; 2002 Jan 31; 45(3):631-9. PubMed ID: 11806714 [Abstract] [Full Text] [Related]
6. Synthesis and characterizations of pyridazine-based iron chelators. Ma Y, Kong X, Chen YL, Hider RC. Dalton Trans; 2014 Dec 07; 43(45):17120-8. PubMed ID: 25311299 [Abstract] [Full Text] [Related]
8. Amido-3-hydroxypyridin-4-ones as iron(III) ligands. Piyamongkol S, Ma YM, Kong XL, Liu ZD, Aytemir MD, van der Helm D, Hider RC. Chemistry; 2010 Jun 01; 16(21):6374-81. PubMed ID: 20397153 [Abstract] [Full Text] [Related]
9. Design and synthesis of fluorinated iron chelators for metabolic study and brain uptake. Ma Y, Roy S, Kong X, Chen Y, Liu D, Hider RC. J Med Chem; 2012 Mar 08; 55(5):2185-95. PubMed ID: 22339047 [Abstract] [Full Text] [Related]
10. Synthesis and characterization of new beta-diketo derivatives with iron chelating ability. Benassi R, Ferrari E, Grandi R, Lazzari S, Saladini M. J Inorg Biochem; 2007 Feb 08; 101(2):203-13. PubMed ID: 17097145 [Abstract] [Full Text] [Related]
11. High affinity iron(III) scavenging by a novel hexadentate 3-hydroxypyridin-4-one-based dendrimer: synthesis and characterization. Zhou T, Liu ZD, Neubert H, Kong XL, Ma YM, Hider RC. Bioorg Med Chem Lett; 2005 Nov 15; 15(22):5007-11. PubMed ID: 16153843 [Abstract] [Full Text] [Related]
12. Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential. Liu ZD, Liu DY, Lu SL, Hider RC. J Pharm Pharmacol; 1999 May 15; 51(5):555-64. PubMed ID: 10411215 [Abstract] [Full Text] [Related]
13. Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease. Gaeta A, Molina-Holgado F, Kong XL, Salvage S, Fakih S, Francis PT, Williams RJ, Hider RC. Bioorg Med Chem; 2011 Feb 01; 19(3):1285-97. PubMed ID: 21236688 [Abstract] [Full Text] [Related]
14. Hexadentate 3-hydroxypyridin-4-ones with high iron(III) affinity: design, synthesis and inhibition on methicillin resistant Staphylococcus aureus and Pseudomonas strains. Zhou YJ, Liu MS, Osamah AR, Kong XL, Alsam S, Battah S, Xie YY, Hider RC, Zhou T. Eur J Med Chem; 2015 Apr 13; 94():8-21. PubMed ID: 25747496 [Abstract] [Full Text] [Related]
15. Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase. Liu ZD, Lockwood M, Rose S, Theobald AE, Hider RC. Biochem Pharmacol; 2001 Feb 01; 61(3):285-90. PubMed ID: 11172732 [Abstract] [Full Text] [Related]
16. Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential. Dobbin PS, Hider RC, Hall AD, Taylor PD, Sarpong P, Porter JB, Xiao G, van der Helm D. J Med Chem; 1993 Aug 20; 36(17):2448-58. PubMed ID: 8355246 [Abstract] [Full Text] [Related]
17. Synthesis and in-vitro antimicrobial evaluation of a high-affinity iron chelator in combination with chloramphenicol. Zhu CF, Qiu DH, Kong XL, Hider RC, Zhou T. J Pharm Pharmacol; 2013 Apr 20; 65(4):512-20. PubMed ID: 23488779 [Abstract] [Full Text] [Related]
18. The design and properties of 3-hydroxypyridin-4-one iron chelators with high pFe(3+) values. Hider RC, Liu ZD, Piyamongkol S. Transfus Sci; 2000 Dec 20; 23(3):201-9. PubMed ID: 11099896 [No Abstract] [Full Text] [Related]